Gavis Pharma earns FDA approval for generic painkiller

Somerset, N.J.-based Gavis Pharmaceuticals — a subsidiary of Mumbai-based Lupin Limited — recently earned approval from the Food and Drug Administration for its hydrocodone bitartrate and acetaminophen tablets.

The tablets are intended to relieve moderate to moderately severe pain.

The FDA approved the painkiller as a generic equivalent of Mikart's hydrocodone bitartrate and acetaminophen tablets.

More articles on supply chain:

FDA adds box warning to birth control device Essure
Fire in Amazon distribution center forces some retailers to pull products off website
Novartis considers selling eye division

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars